Related Experiment Video
Updated: Jul 11, 2026

Postconditioning with Lactate-enriched Blood for Cardioprotection in ST-segment Elevation Myocardial Infarction
Published on: May 28, 2019
Marked hypocalcemia after tocolytic magnesium sulphate therapy
Anwar H Nassar1, Ibrahim Salti, Nisrine N Makarem
1Department of Obstetrics and Gynecology, American University of Beirut Medical Center, Beirut, Lebanon.
Magnesium sulfate (MgSO4) therapy for preterm labor can cause severe hypocalcemia, even with short durations. This case highlights the potential need for routine calcium monitoring during MgSO4 treatment.
Area of Science:
- Obstetrics and Gynecology
- Maternal-Fetal Medicine
- Pharmacology
Background:
- Magnesium sulfate (MgSO4) is a commonly used tocolytic agent to manage preterm labor.
- Symptomatic hypocalcemia is an infrequently reported complication of MgSO4 therapy.
Observation:
- A 38-year-old woman at 24 3/7 weeks gestation presented with preterm labor and received MgSO4.
- Twenty hours into therapy, she developed chest pain and was found to have severe hypocalcemia (total serum calcium 5.5 mg/dL) despite therapeutic serum magnesium levels.
- Laboratory findings included low serum uric acid and phosphate, and elevated 24-hour urine calcium excretion.
Findings:
- The patient's hypocalcemia and other laboratory abnormalities resolved postpartum.
- Urine calcium levels normalized on postpartum day 2.
- This case demonstrates that even short courses of MgSO4 can precipitate severe hypocalcemia.
Implications:
- Routine monitoring of serum calcium levels may be warranted in patients receiving MgSO4 for tocolysis.
- Clinicians should be aware of the potential for severe hypocalcemia as a complication of MgSO4 therapy.
- Further studies are needed to establish guidelines for calcium monitoring during MgSO4 treatment.
Related Concept Videos
Skeleton and Calcium Homeostasis
Ionic Bonds
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Introduction to Electrolytes
Role of Sodium
One...
Heart Failure Drugs: Inotropic Agents
